Neopterin and alpha-interferon in patients affected by Kaposi's sarcoma from Africa.

[1]  G. Melillo,et al.  Urinary neopterin and immunological features in patients with Kaposi's sarcoma. , 1988, European journal of cancer & clinical oncology.

[2]  E. Peterson,et al.  Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media. , 1988, Cancer research.

[3]  E. Werner,et al.  HIV seroconversion in health care workers. , 1987, JAMA.

[4]  S. Friedman,et al.  DECLINES IN PROPORTION OF KAPOSI'S SARCOMA AMONG CASES OF AIDS IN MULTIPLE RISK GROUPS IN NEW YORK CITY , 1987, The Lancet.

[5]  U. Bredberg,et al.  CLINICAL CASE DEFINITION OF AIDS IN AFRICAN ADULTS , 1987, The Lancet.

[6]  M. Popovič,et al.  ISOLATION OF HIV-1 FROM MONOCYTES BUT NOT T LYMPHOCYTES , 1987, The Lancet.

[7]  E. Werner,et al.  Interferon-gamma-induced degradation of tryptophan by human cells in vitro. , 1987, Biological chemistry Hoppe-Seyler.

[8]  R. Bauer,et al.  LANGERHANS CELL AS PRIMARY TARGET AND VEHICLE FOR TRANSMISSION OF HIV , 1987, The Lancet.

[9]  S. Skidmore,et al.  α-INTERFERON IN ANTI-HIV POSITIVE PATIENTS , 1987, The Lancet.

[10]  D. Ho,et al.  Pathogenesis of infection with human immunodeficiency virus. , 1987, The New England journal of medicine.

[11]  E. Werner,et al.  Human macrophages degrade tryptophan upon induction by interferon-gamma. , 1987, Life sciences.

[12]  E. Werner,et al.  In vivo activation of CD4+ cells in AIDS. , 1987, Science.

[13]  E. Werner,et al.  Determination of neopterin in serum and urine. , 1987, Clinical chemistry.

[14]  J. Levy,et al.  Absence of antibodies to the human immunodeficiency virus in sera from Africa prior to 1975. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Byrne,et al.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells , 1986, Infection and immunity.

[16]  F. Real,et al.  Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. , 1986, Cancer research.

[17]  E. Werner,et al.  ARE HOMOSEXUALS LESS AT RISK OF AIDS THAN INTRAVENOUS DRUG ABUSERS AND HAEMOPHILIACS? , 1985, The Lancet.

[18]  E. Gelmann,et al.  Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Cozzi,et al.  URINARY NEOPTERIN, A USEFUL MARKER FOR AIDS? , 1985, The Lancet.

[20]  G. Gaudernack,et al.  Enriched Langerhans Cells Express More HLA‐DR Determinants Than Blood‐Derived Adherent Cells (Monocytes and Dendritic Cells) , 1985, Scandinavian journal of immunology.

[21]  D. Fuchs,et al.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.

[22]  A. Friedman-kien.  Kaposi's sarcoma: an opportunistic neoplasm. , 1984, The Journal of investigative dermatology.

[23]  C. Vogel,et al.  Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. , 1984, Seminars in oncology.

[24]  L. Cooper,et al.  IS PRESENCE OF INTERFERON PREDICTIVE FOR AIDS? , 1983, The Lancet.

[25]  H. Murray,et al.  Lymphokine enhances oxygen-independent activity against intracellular pathogens , 1983, The Journal of experimental medicine.

[26]  F. Muggia,et al.  Kaposi's sarcoma: a new staging classification. , 1983, Cancer treatment reports.

[27]  S. Russell,et al.  Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. , 1983, Journal of immunology.

[28]  J. Parry,et al.  INTERFERON ASSAY AS A DIAGNOSTIC TEST , 1981, The Lancet.